Quantcast
Home (page 3)

Tag Archives: Food and Drug Administration

J&J unit settles state Risperdal claims for $181M

Johnson & Johnson has agreed to pay a record $181 million to settle claims brought by New York and 36 other states that the company’s Janssen Pharmaceuticals unit improperly marketed Risperdal and other anti-psychotic drugs for “off-label” uses.

Read More »

Medtronic bone graft suit isn’t preempted, says trial court

Federal law does not preempt a product liability suit brought by a woman who claimed she suffered injuries as a consequence of Medtronic’s promotion of a bone graft device for “off-label” uses, a California trial court has ruled in denying ...

Read More »

FDA warns of post-surgery codeine use in children

WASHINGTON – After three children died and a fourth suffered life-threatening respiratory problems after being given the pain reliever codeine following surgeries to remove tonsils and adenoids, the Food and Drug Administration is warning physicians and parents about the use ...

Read More »

Report urges FCC to consider new rules on cell phone risk

A recent report from the Government Accountability Office is urging the Federal Communications Commission to take another look at old rules on cell phone exposure in light of new scientific studies on long term health risks, including cancer.

Read More »

Benchmarks: Woman blinded by colored contacts faces FDA preemption

Apparently, there is no end to what you can buy at a dollar store. One South Carolina woman found to her ever-lasting regret that dollar store shoppers can actually buy prescription colored contact lenses – without the bother of a ...

Read More »

Glaxo settles marketing fraud charges for record $3 billion

GlaxoSmithKline has agreed to plead guilty and pay $3 billion to resolve charges that the pharmaceutical giant fraudulently marketed the prescription drugs Paxil, Wellbutrin and Avandia, the U.S. Justice Department has announced.

Read More »